AGP Picks
View all

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
fallback image
Sep. 8, 2026

CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

GlobeNewswire, Inc.

fallback image
Sep. 8, 2026

Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer

GlobeNewswire, Inc.

fallback image
Sep. 8, 2026

Register Now: Limited Seating Remains for HMG Strategy’s Sept. 10 Boston C-Level Technology Leadership Summit

GlobeNewswire, Inc.

fallback image
Sep. 8, 2026

Back to School, Back to Healthy Routines

Barnstable County - Massachusetts

fallback image
Sep. 8, 2026

MetaShape Pharma to Showcase New Data and Strategic Updates at MedInvest and RESI Life Sciences Investor Conferences

EIN Presswire

fallback image
Sep. 17, 2026

Wise Up PR Celebrates Five Years As A Boutique B2B Public Relations Agency

EIN Presswire

fallback image
Sep. 8, 2026

Purna Pharmaceuticals Strengthens Leadership Team With Appointment of Industry Veterans

GlobeNewswire, Inc.

fallback image
Sep. 3, 2026

MASSACHUSETTS EARNS 49 MEDALS AT SKILLSUSA CHAMPIONSHIPS

EIN Presswire

fallback image
Sep. 7, 2026

Zealand Pharma - Transactions related to share buy-back program (week 36, 2026)

GlobeNewswire, Inc.

fallback image
Sep. 2, 2026

Boston Hair Restoration Surgeon Weighs In On Rising Demand For Treatment

EIN Presswire

fallback image
Sep. 16, 2026

Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors

GlobeNewswire, Inc.

fallback image
Sep. 17, 2026

Former Senior PBGC Attorney Offers Practical Guidance on PBGC Distress and Involuntary Terminations

EIN Presswire

fallback image
Aug. 31, 2026

Health Catalyst to Participate in Upcoming Investor Conference

GlobeNewswire, Inc.

fallback image
Aug. 25, 2026

Nu-Tek BioSciences to Attend BPI East 2026 in Boston, Connecting Animal-Free Culture Media Nutrients with Pharma Customer Growth Strategies

GlobeNewswire, Inc.

fallback image
Sep. 17, 2026

Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)

GlobeNewswire, Inc.

fallback image
Sep. 17, 2026

Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program

GlobeNewswire, Inc.

fallback image
Sep. 4, 2026

Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference

GlobeNewswire, Inc.

fallback image
Sep. 4, 2026

Merit Medical to Participate in Upcoming Investors Conferences in September

GlobeNewswire, Inc.

fallback image
Sep. 4, 2026

City receives $50,000 grant for Massachusetts Street bus stop improvements 

City of Lawrence - Kansas

fallback image
Sep. 16, 2026

Censinet Recognized in the 2026 Gartner® Coolest Vendor Innovations for Assurance: GRC and TPRM

EIN Presswire

Sign up for:

Massachusetts Healthcare Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by: